Oncoloxía médica
Servicio
Beckman Research Institute
City of Hope, Estados UnidosPublicacións en colaboración con investigadores/as de Beckman Research Institute (7)
2024
-
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
Annals of Oncology, Vol. 35, Núm. 9, pp. 805-816
-
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study
eClinicalMedicine, Vol. 73
2023
-
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
Expert Review of Anticancer Therapy, Vol. 23, Núm. 1, pp. 95-106
-
Liquid Biopsy Assessment of Molecular Residual Disease in Localized Colorectal Cancer: Is It Ready for Prime Time?
JAMA Oncology
2022
-
Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA
Clinical Epigenetics, Vol. 14, Núm. 1
2021
-
Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy
Advances in Cancer Research (Academic Press Inc.), pp. 231-304
2014
-
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Cancer, Vol. 120, Núm. 10, pp. 1453-1461